Ixazomib
C16007
Phase 1 small_molecule completed
Quick answer
Ixazomib for Light-Chain Amyloidosis is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Light-Chain Amyloidosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed